Install
Ajanta Pharma to hold 47th annual general meeting on July 16 Indian Pharma Post Get the latest News & Research on Pharma industry, Viewpoints, Events, Videos, statistics, indianpharmapost.com
- 188articles · 30d
- 7+ hour agolatest article
- Aug 14, 2026earliest in window
- 89%with images
- 245avg words
- Medical 138
- Health & Wellness 101
- Economy, Business & Finance 81
- Health 74
- Business & Industrial 65
- Finance & Business 33
- Science & Technology 21
- News 15
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Biocon inks 10-year deal to supply breast cancer therapy to Brazil
4+ day, 19+ hour ago (256+ words) Biocon Limited has signed a landmark partnership agreement with Bahiafarma and Bionovis for Pertuzumab in Brazil. This collaboration marks a significant step forward in scaling the production and commercialization of this HER2-positive breast cancer therapy under the country's Productive Development…...
Superluminal Medicines raises $60 million to push obesity drug into clinic
5+ day, 2+ hour ago (62+ words) Indian Pharma Post Superluminal Medicines raises $60 million to push obesity drug into clinic Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants Implementing a digital transformation in chemical operations to maximize profitability The complexity of compliance The…...
GSK moves toward first Phase III trial of mRNA flu vaccine targeting both HA and NA
1+ week, 3+ day ago (84+ words) Indian Pharma Post GSK moves toward first Phase III trial of mRNA flu vaccine targeting both HA and NA GSK plans to begin a Phase III efficacy trial in September 2026 Chasing Consistency: Centralizing operations data is the key to optimizing…...
Novartis’ Remibrutinib delivers positive Phase III results in relapsing multiple sclerosis
1+ week, 3+ day ago (47+ words) The results point to potential benefits beyond relapse control Medtronic to invest $700 million in Hong Kong surgical robotics firm Scan.com raises $220 million to expand US medical imaging network India Glycols demerges biopharma business into separate entity Dr. Vineet Talwar…...
Lilly to acquire Merida Biosciences for $2.875 billion in autoimmune disease push
1+ week, 5+ day ago (65+ words) Merida's lead drug candidate, MER511, is already being tested in a Phase 1 trial for Graves' disease and thyroid eye disease Lilly to acquire Merida Biosciences for $2.875 billion in autoimmune disease push Sun Pharma joins White House push on US drug pricing…...
Syneos Health opens Hyderabad GCC to accelerate AI-led healthcare innovation
2+ week, 1+ day ago (312+ words) New hub, Syneos Health’s largest in Asia and third-largest globally, will focus on AI, data engineering and technology for clinical development, patient safety and commercialisation US-based biopharmaceutical solutions company Syneos Health has launched a new Global Capability Centre (GCC) in…...
University of Toronto researchers develop tRNA approach to target genetic diseases
2+ week, 1+ day ago (652+ words) Engineered tRNA restores full-length protein production in cystic fibrosis models, opening the door to a potential new class of RNA therapeutics Researchers at the University of Toronto have developed a next-generation RNA therapeutic approach that could potentially treat a broad…...
Delhi sees rising seasonal influenza activity as H1N1 cases cross 1,700
2+ week, 4+ day ago (405+ words) Delhi is witnessing increased seasonal influenza activity, with 1,777 H1N1 cases reported through August 20, 2026, while Agilus Diagnostics has observed a H1N1 positivity rate of nearly 30% among individuals tested at its reference laboratory over the past week. Health experts, however, have advised against unnecessary…...
Creative Medical completes Olastrocel trial enrollment as it sets sights on FDA Phase 3 path
2+ week, 5+ day ago (80+ words) Indian Pharma Post Creative Medical completes Olastrocel trial enrollment as it sets sights on FDA Phase 3 path The Business of Genomics: Opportunities, Investments, and Innovation in India Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants Implementing…...
Chai Discovery and Bristol Myers Squibb team up to accelerate AI-driven antibody discovery
2+ week, 5+ day ago (68+ words) Bristol Myers Squibb will use Chai’s AI models and molecular-design platform to identify antibody candidates across its portfolio India must now become the laboratory of the world: Anupriya Patel India’s genomics leaders to join Indian Pharma Post E-Conference on August…...